Tag: Vaccines
Vaccination Reduces Incidence of SARS-CoV-2 Among Adolescents
Vaccine effectiveness was 87.8 and 89.1 percent against documented and symptomatic infection, respectively
Physician’s Briefing Weekly Coronavirus Roundup
Vaccine Effectiveness Lower for Teens With Predominant Omicron
VE increased for adolescents aged 16 to 17 years at seven or more days after a third booster dose during omicron predominance
Homologous Pfizer-BioNTech Booster Safe for Adolescents
Reactions to booster occur with similar frequency as after receipt of second vaccine dose, generally mild to moderate
Vaccination Ups Infection-Acquired Immunity Against SARS-CoV-2
Two doses of BNT162b2 vaccine linked to high short-term protection against infection, which wanes after six months
Vaccine Rollout Linked to Drop in Severe COVID-19 in Dialysis Patients
And, patients on maintenance dialysis who received COVID-19 vaccination had decreasing antibody titers over time
Physician’s Briefing Weekly Coronavirus Roundup
COVID-19 Vaccination Tied to Decline in Distress in U.S. Adults
Decreases in distress and perceived risks for infection, hospitalization, and death reported by those receiving at least one dose of vaccine
New Sanofi-GSK COVID-19 Vaccine Highly Effective, Companies Say
In laboratory studies, two doses of the vaccine stimulated the production of more neutralizing antibodies than an approved mRNA vaccine
Low Risk Seen for Second Allergic Reaction to mRNA COVID-19 Vaccine
Of 1,366 patients with immediate allergic reaction to first dose, six developed severe immediate allergic reaction after second dose
